Proteomic Analysis in Paediatric Diabetes Type 1 (PAPD)

The aim of the present study is to investigate a targeted proteomic analysis in plasma of children - of Greek origin- with type 1 diabetes (DT1) and its correlation with the electrophysiological findings that accompany diabetic peripheral neuropathy. Diabetic neuropathy is the most frequent chronic complication in adults with DT1 and rarely appears in childhood. Nevertheless, cases of acute mononeuritis have been described at the time of diagnosis of DT1. According to recent reports several biomarkers, including proteomic analysis, have been proposed for the early detection of peripheral neuropathy in children and young adults with T1DM. In the present study the researchers will attempt to investigate the role of biomarkers with targeted proteomic analysis in the plasma of children with DT1 in combination with an electrophysiological study, which includes a nerve conduction study, to detect early diabetic peripheral neuropathy, before the appearance of clinical manifestations.

NCT Number	NCT04257877
Lead Sponsor	Aristotle University Of Thessaloniki
Conditions	Diabetes Type 1, Proteomics, Diabetic Peripheral Neuropathy
Enrollment	50 participants
Start Date	2018-11-20
Primary Completion	2025-01-20 (estimated)
Study Completion	2025-01-20 (estimated)
Updated on ClinicalTrials.gov	2024-07-31